The promise of a plant-based feed additive that outperforms a standard antibiotic across multiple bacterial challenges is the kind of validated, measurable result that moves aquaculture from reactive treatment toward proactive health management. This study on *Annona glabra* methanolic leaf extract (AgME) in Basa fish is not merely another entry in the catalog of natural alternatives; it is an integrated demonstration of what a well-characterized phytochemical can achieve when antibacterial, antioxidant, and host-supportive properties are combined in a single application. For an industry constrained by antimicrobial resistance and residue concerns, that convergence matters.
The data are specific and instructive. In vitro, AgME inhibited all three target pathogens, *Edwardsiella ictaluri*, *Aeromonas veronii*, and *Vibrio parahaemolyticus*, while exhibiting a DPPH scavenging IC50 of 39.521 µg/mL, a figure that signals biologically relevant antioxidant capacity. More compelling is the in vivo performance: dietary supplementation at 2% AgME reduced cumulative mortality, preserved growth, and improved hematological and splenic recovery in challenged fish, consistently matching or exceeding doxycycline across the board. Notably, even unchallenged fish fed AgME showed higher survival than those receiving the antibiotic under identical husbandry conditions. This suggests the extract is doing more than suppressing pathogens, it is supporting the host. This aligns with findings from related work in our publication, such as the validation of Mushroom-based feed boosts immunity in European seabass, study validates, where fungal-derived additives enhanced immune parameters, and the exploration of Plant Root Extract Shows Antibacterial Promise Against Aquaculture Pathogen, which similarly targets antibiotic-resistant pathogens. The pattern is clear: the industry is moving beyond single-mode therapies toward integrated, host-supportive feed strategies.
What remains unresolved is the mechanism. The study motivates further work to define the phytochemical profile of AgME and clarify how the observed protection arises, whether through direct bactericidal action, immune modulation, antioxidant mitigation of tissue damage, or a synergistic combination. This is not a limitation of the study but a necessary next step. For producers and feed formulators, the practical takeaway is that a 2% inclusion rate of a validated leaf extract offers a reproducible, peer-reviewed baseline for reducing antibiotic dependency in Basa culture. The real-world consequence is straightforward: a measurable reduction in mortality and residue risk, paired with preserved growth performance, is a value proposition that warrants scaled field trials. We will be watching for the dose-response refinement and the phytochemical characterization that will determine whether this promising candidate becomes a practical tool.